The "Goddess stack" is a marketing term used by peptide clinics to describe multi-peptide protocols designed for women. A typical Goddess stack includes PT-141 (bremelanotide) for libido, GHK-Cu for skin quality, BPC-157 for gut and tissue healing, and sometimes growth hormone peptides or kisspeptin for hormonal balance. The components are not exclusive to women, but the stacks are packaged and dosed with female physiology in mind. GHK-Cu for skin is covered in our GHK-Cu skin anti-aging guide. BPC-157 gut benefits are detailed in our BPC-157 gut health article.
Key Takeaway
Most peptides in the Goddess stack are not gender-specific. PT-141 is the one exception: it is FDA-approved specifically for premenopausal women with hypoactive sexual desire disorder (HSDD). The other peptides (GHK-Cu, BPC-157, GH secretagogues) work the same way in men and women. The "Goddess" branding is largely marketing, though some dosing adjustments for body weight and hormonal cycles may be appropriate for women.
What Is Actually in the Goddess Stack?
The Goddess stack varies by clinic, but the core components fall into four categories: sexual health, skin and beauty, healing and recovery, and hormonal optimization. What most versions include:
PT-141 (bremelanotide): A melanocortin receptor agonist FDA-approved as Vyleesi for HSDD in premenopausal women. It works through the central nervous system to increase sexual desire, not through hormones or blood flow. The standard dose is 1.75 mg subcutaneous injection at least 45 minutes before sexual activity, no more than once per 24 hours and no more than 8 doses per month.[1]
GHK-Cu: A copper-binding tripeptide that stimulates collagen synthesis, skin elasticity, and wound healing. In the Goddess stack, it targets skin quality, hair health, and overall tissue repair. A randomized clinical trial showed 31.6% wrinkle volume reduction after 8 weeks of topical use.[2] For hair-specific protocols, see GHK-Cu hair growth.
BPC-157: A gastric-derived peptide with extensive animal data showing tissue repair, gut healing, and anti-inflammatory effects. In women-focused stacks, it is often included for gut health support (many women seek peptide therapy partly because of digestive complaints) and for general recovery.[3]
Growth hormone peptides: Sermorelin, ipamorelin, or CJC-1295 are sometimes included for body composition, sleep quality, and general metabolic support. These work the same in men and women, though women may use lower doses.
Why Is There a Women-Specific Peptide Stack?
Three main factors drive the existence of women-specific stacks:
View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
PT-141's approval status. Vyleesi (bremelanotide) is one of the few peptides with an FDA approval, and that approval is specifically for women. This gives clinics a legitimate, FDA-backed centerpiece for women's stacks. The clinical trial data (the RECONNECT program) enrolled 1,247 premenopausal women and demonstrated statistically significant improvements in both sexual desire and reduction of distress associated with low desire.[1]
Hormonal considerations. Women's hormonal cycles affect peptide metabolism and response. Some practitioners adjust dosing around the menstrual cycle, recommending certain peptides during the follicular phase and others during the luteal phase. The evidence for cycle-based dosing of these specific peptides is largely theoretical rather than clinically validated, but it is a common practice pattern.
Marketing positioning. The peptide therapy market has historically been male-dominated (testosterone replacement, growth hormone, bodybuilding peptides). Goddess stacks, Venus protocols, and similar branded programs are attempts to reach female patients who might not relate to the existing, male-coded peptide marketing. The underlying compounds are mostly the same.
Are Peptide Responses Actually Different in Women?
For most peptides in this category, the pharmacology does not change based on sex. GHK-Cu stimulates collagen through the same pathways in men and women. BPC-157 promotes angiogenesis and tissue repair regardless of sex. Growth hormone secretagogues act on the same pituitary receptors.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →There are some meaningful differences worth noting:
Body weight and composition: Women generally have lower body weight and higher body fat percentage than men, which can affect peptide distribution and dosing. Some practitioners adjust doses downward for women, though standardized guidelines do not exist for most of these compounds.
Hormonal interactions: Estrogen and progesterone can interact with some peptide pathways. For example, growth hormone secretion is influenced by estrogen status, which means the response to GH secretagogues may differ between premenopausal and postmenopausal women. This is an area where clinical data is thin.
PT-141 specifically: The clinical trial data for PT-141 is exclusively in women (for the FDA approval). Off-label use in men shows efficacy too, but the approval is sex-specific because HSDD was defined as a clinical entity primarily in women when the drug was developed.[1]
Kisspeptin: Some advanced Goddess stacks include kisspeptin, a peptide that stimulates GnRH (gonadotropin-releasing hormone) release. Kisspeptin plays a role in regulating the menstrual cycle and has been studied for its effects on reproductive hormone release in women. Research at Imperial College London has shown that kisspeptin can increase LH pulsatility in women, which could have applications for certain hormonal conditions.[4]
How Does the Goddess Stack Compare to Other Peptide Stacks?
| Stack | Primary Focus | Key Peptides | Women-Specific? |
|---|---|---|---|
| Goddess Stack | Libido, skin, recovery, hormonal balance | PT-141, GHK-Cu, BPC-157, GH peptides | PT-141 approval is; rest are not |
| Glow Stack | Skin, hair, appearance | GHK-Cu, BPC-157, TB-500 | No |
| Fountain of Youth | Anti-aging, longevity | GHK-Cu, epithalon, BPC-157, TB-500 | No |
| Barbie Peptide (PT-141 solo) | Sexual desire | PT-141 only | FDA approval is; off-label in men |
The overlap between these stacks is significant. GHK-Cu and BPC-157 appear in nearly every combination. The main differentiator for the Goddess stack is the inclusion of PT-141 and the hormonal optimization component (kisspeptin or lower-dose GH peptides). barbie peptide PT-141 bremelanotide
What Should Women Watch Out for with Peptide Stacks?
Several practical considerations apply specifically to women using peptide protocols:
PT-141 nausea. The most common side effect of PT-141 is nausea, occurring in about 40% of users in clinical trials. This tends to be worst with the first few doses. Taking an anti-nausea medication (ondansetron) before the first use and eating a light meal can reduce this. PT-141 can also cause transient blood pressure increases, so women with uncontrolled hypertension should not use it.[1]
Pregnancy and fertility. None of these peptides have been studied in pregnant women. PT-141 is specifically contraindicated during pregnancy. Women who are pregnant, planning to become pregnant, or breastfeeding should avoid peptide stacks entirely unless specifically advised otherwise by a healthcare provider.
Hormonal contraception interactions. The interaction between peptide protocols and hormonal birth control (oral contraceptives, IUDs, implants) has not been studied. There is no evidence that peptides interfere with contraceptive efficacy, but the absence of data means uncertainty rather than safety.
Copper levels (GHK-Cu). Women taking copper-containing IUDs should inform their provider before starting GHK-Cu, as the additional copper load may be relevant. Baseline copper testing is recommended.
Marketing vs. medicine. The "Goddess" branding is designed to sell. Evaluate the actual peptide components and their evidence base rather than the packaging. A $500/month "Goddess stack" from Clinic A may contain the same compounds as a $200/month generic protocol from Clinic B. The peptides do not know what the label says.
What Does a Typical Goddess Stack Protocol Look Like?
A representative protocol structure, though individual clinic approaches vary:
Month 1-3 (Foundation phase):
- GHK-Cu: 1 mg subcutaneous injection daily for 30 days, then 30 days off
- BPC-157: 250-500 mcg subcutaneous injection daily
- PT-141: 1.75 mg subcutaneous as needed, max 8 doses/month
Month 4-6 (Optimization phase):
- Continue GHK-Cu cycling (30 on, 30 off)
- Continue BPC-157 as needed
- Add GH secretagogue (sermorelin 100-200 mcg or ipamorelin 100-200 mcg at bedtime, 5 days on, 2 days off)
- Continue PT-141 as needed
Ongoing maintenance:
- Periodic GHK-Cu cycles
- PT-141 as needed
- Quarterly bloodwork (hormone panel, IGF-1, copper, metabolic panel)
Total monthly cost for a full Goddess stack protocol typically ranges from $300-$800, depending on the clinic and which peptides are included. PT-141 (as the branded Vyleesi) costs significantly more through traditional pharmacy channels than through compounding pharmacies.
Frequently Asked Questions
Is the Goddess stack only for younger women?
No. Women of various ages use these protocols. PT-141 is FDA-approved for premenopausal women, but it is used off-label in postmenopausal women as well. GHK-Cu, BPC-157, and GH peptides are used by women across age ranges. Dosing may be adjusted based on age and hormonal status.
Can I just use PT-141 without the rest of the stack?
Yes. PT-141 works independently and does not require other peptides to be effective. The RECONNECT clinical trials studied PT-141 as a standalone therapy. The stack approach bundles it with other peptides for a more comprehensive protocol, but standalone use is the FDA-studied approach. barbie peptide PT-141 bremelanotide
Do peptides interact with hormone replacement therapy (HRT)?
There is limited published data on interactions between peptide stacks and HRT. PT-141 works through melanocortin receptors in the brain, not through hormonal pathways, so direct interaction with estrogen or progesterone supplementation is unlikely. GH secretagogues may interact with HRT-related changes in IGF-1. Discuss all concurrent therapies with your provider.
Are there any peptides women should avoid?
There are no peptides that are categorically contraindicated in women compared to men. The main concern is pregnancy: avoid all experimental peptides during pregnancy and breastfeeding. Women with copper metabolism issues should avoid GHK-Cu, and those with uncontrolled hypertension or cardiovascular disease should avoid PT-141.
Why is it called the "Goddess stack"?
The name is pure marketing. It evokes femininity, beauty, and empowerment to appeal to women who might not connect with the traditionally male-oriented language of peptide therapy. The peptides themselves are gender-neutral molecules (with the exception of PT-141's FDA label). Other clinics use names like "Venus protocol" or "feminine importantity stack" for similar combinations.
How does the Goddess stack differ from the Barbie peptide?
The "Barbie peptide" refers specifically to PT-141 (bremelanotide) and its parent compound Melanotan II. The Goddess stack includes PT-141 as one component among several. Think of the Barbie peptide as a single tool and the Goddess stack as a toolbox that includes it alongside peptides for skin, healing, and metabolic support.
Does FormBlends offer the Goddess stack?
FormBlends provides SEMAGLUTIDE and TIRZEPATIDE through licensed telehealth providers. This article is educational content about women-targeted peptide protocols. Consult with a qualified provider for access to specific peptide stacks.
Medical References
- Kingsberg SA, et al. Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstet Gynecol. 2019;134(5):899-908. PMID: 31599840
- Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. PMC4508379
- Sikiric P, et al. Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications. Curr Neuropharmacol. 2016;14(8):857-865. PMID: 29898100
- Jayasena CN, et al. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest. 2014;124(8):3667-3677. PMID: 25051443
- FDA. VYLEESI (bremelanotide injection) Prescribing Information. U.S. Food and Drug Administration. 2019. FDA Label
This article is for educational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider before starting any medication or protocol. FormBlends connects you with licensed providers who can evaluate your individual health needs.
Reviewed by the FormBlends Medical Team. Last updated: 2026-04-10